Search

everythinglearnresearchcommunity

for

Search:↓

A new gel form of minoxidil is equally effective for hair growth and safer for the heart and other organs than the traditional solution.

Matriptase-2 helps control iron levels by suppressing hepcidin, and its deficiency can cause iron-deficiency anemia.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

BMPR1a-ECD reduces wrinkles much more effectively than retinoic acid.

Fibromodulin treatment helps reduce scarring and improves wound healing by making it more like fetal healing.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

RADA16-I can effectively deliver and release mangiferin, improving its solubility and bioavailability.

Prdm1 is necessary for early whisker development in mice but not for other hair, and its absence changes nerve and brain patterns related to whiskers.

Adding TERT and BMI1 to certain skin cells can improve their ability to create hair follicles in mice.

Certain skin proteins can form anchoring structures without the protein AMACO.

CMC2.24 and CMC2.23 reduce melanin safely and effectively.

Minoxidil can stop the growth of ovarian cancer cells without harming the heart.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

Propranolol affects heart rate and renin levels in minoxidil-treated patients.

Laminin-511 is essential for proper melanocyte movement and development in mice.

A 30-year-old man with rare skin conditions improved with antibiotics and surgery, hinting at a link to rosacea.

SMR-2 and SMR-6 are much more toxic than retinoic acid, causing severe side effects.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

Polygoni Multiflori Radix may help reduce skin aging by lowering collagenase and elastase activity.

Deleting MED1 in skin cells causes hair loss and skin changes.

Ranitidine and finasteride lower TMAO levels, reducing heart and kidney damage by changing gut bacteria.

The mTurq2-Col4a1 mouse model shows how the basement membrane develops in live mammals.

Minoxidil prevents serotonin loss from MDMA by affecting potassium channels and increasing Akt phosphorylation.

Minoxidil can cause erythema multiforme, even if patch tests are negative.

miR-203a-3p helps hair follicle stem cells become specialized by targeting Smad1.

Minoxidil protects heart and improves recovery.

The mineralocorticoid receptor temporarily affects mouse skin development, but the glucocorticoid receptor has a more lasting impact.